Stephan Mielke

Stephan Mielke is a Professor of Hematology and Cell Therapy at Karolinska Institutet and Head of the Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST) at Karolinska University Hospital. He holds dual roles as a clinician and researcher, specializing in advanced therapy medicinal products (ATMPs), particularly CAR T-cell therapy and allogeneic stem cell transplantation. His work focuses on translating innovations from bench-to-bedside, with a primary aim of improving cure rates for leukemia, lymphoma, multiple myeloma, and solid tumors while maintaining quality of life.

• Affiliations: Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine (BCM), Karolinska Comprehensive Cancer Center, Karolinska ATMP Center.
• Education: MD from Medical School (exact institution not specified), PhD from Georg-August University in Göttingen (Germany), postdoctoral training at NIH (USA).

Research interests include immune system modulation, gene- and cell-based therapies, immune reconstitution post-transplant, and overcoming treatment resistance. Mielke leads SWECARNET, Sweden’s CAR T-cell network, fostering collaboration between academia, healthcare, and industry. He has published over 150 papers and holds an H-index of 50, contributing to high-impact journals like NEJM and Lancet.

Teaching spans three decades, emphasizing interdisciplinary approaches and mentorship. He supervises master’s and doctoral candidates, integrating clinical and academic training.